These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 911535)

  • 1. [Comparative study of the effects of various antiarrhythmic drugs on the frequency of ventricular response during established atrial fibrillation].
    Bracchetti D; Frabetti L; Mambelli M; Stefanini A; Magnani B
    Boll Soc Ital Cardiol; 1977; 22(1):51-5. PubMed ID: 911535
    [No Abstract]   [Full Text] [Related]  

  • 2. Plasma digoxin concentrations in patients with atrial fibrillation and indications for the association with other antiarrhythmic agents.
    Cargnelli G; Domeneghetti F; Ferrari M; Malacini P; Roberti G
    Int J Clin Pharmacol Biopharm; 1977 Aug; 15(8):384-8. PubMed ID: 892956
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Influence of cardiac agents on the diastolic irritability of the ventricular myocardium. Consequences for pacemaker therapy].
    Doenecke P
    Ann Univ Sarav Med; 1976; 23(2):81-122. PubMed ID: 938002
    [No Abstract]   [Full Text] [Related]  

  • 4. [Pharmacologic maintenance of sinusal rhythm and/or control of the ventricular response in patients with atrial fibrillation or flutter].
    López Gil M; Arribas F; Hernández Afonso J; Angel Santos M; García-Cosío F
    Rev Esp Cardiol; 1996; 49 Suppl 2():32-41. PubMed ID: 8755694
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Comparison of the antiarrhythmic action of ajmaline, N-n-propylajmalinehydrogen-tartrate and 4-[3'-diethylamino-2'-hydroxypropyl]-ajmalinehydrogentartrate (Tachmalcor) with their hemodynamic and cardiac side-effects].
    Femmer K; Grünheid K
    Pharmazie; 1976; 31(1):33-6. PubMed ID: 1257276
    [No Abstract]   [Full Text] [Related]  

  • 6. Inotropic and chronotropic effects of antiarrhythmic agents onisolated blood-perfused canine ventricular tissue.
    Hashimoto K; Tsukada T; Matsuda H
    Recent Adv Stud Cardiac Struct Metab; 1976 May 26-29; 11():451-5. PubMed ID: 1031944
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Anti-arrhythmia agents].
    Kaufmann G
    Med Klin; 1974 May; 69(18):778-86. PubMed ID: 4134645
    [No Abstract]   [Full Text] [Related]  

  • 8. [Myocardial excitability under the influence of digitalis glycosides and anti-arrhythmia agent].
    Doenecke VP
    Fortschr Med; 1977 Jan; 95(3):163-6. PubMed ID: 838426
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Is there a role for digoxin in atrial fibrillation without heart failure?
    Master J; Schweitzer P
    Cardiol J; 2009; 16(5):483-6. PubMed ID: 19753533
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical assessment of clonidine in the treatment of new-onset rapid atrial fibrillation: a prospective, randomized clinical trial.
    Simpson CS; Ghali WA; Sanfilippo AJ; Moritz S; Abdollah H
    Am Heart J; 2001 Aug; 142(2):E3. PubMed ID: 11479482
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Metabolic effects of bunaftine, a new antiarrhythmic agent: comparison with quinidine, ajmaline, procainamide, xylocaine and propranolol.
    Castellucci A
    Arzneimittelforschung; 1976 Feb; 26(2):241-4. PubMed ID: 947206
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Atrial fibrillation: what are the effects of drug therapy on the effectiveness and complications of electrical cardioversion?
    Sarubbi B; Ducceschi V; D'Andrea A; Liccardo B; Santangelo L; Iacono A
    Can J Cardiol; 1998 Oct; 14(10):1267-73. PubMed ID: 9852940
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Beta-blockers versus digoxin to control ventricular rate during atrial fibrillation.
    Veloso HH; de Paola AA
    J Am Coll Cardiol; 2005 Jun; 45(11):1905-6; author reply 1906-7. PubMed ID: 15936626
    [No Abstract]   [Full Text] [Related]  

  • 14. [Can atrial fibrillation be managed without anti-arrhythmia drugs?].
    Blanc JJ; Mansourati J
    Arch Mal Coeur Vaiss; 1994 Sep; 87 Spec No 3():63-7. PubMed ID: 7786126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rate-control versus conversion strategy in postoperative atrial fibrillation: a prospective, randomized pilot study.
    Lee JK; Klein GJ; Krahn AD; Yee R; Zarnke K; Simpson C; Skanes A; Spindler B
    Am Heart J; 2000 Dec; 140(6):871-7. PubMed ID: 11099990
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [The interaction of antiarrhythmic drugs with other drugs].
    Yamaguchi I
    Kokyu To Junkan; 1985 Aug; 33(8):956-69. PubMed ID: 2866571
    [No Abstract]   [Full Text] [Related]  

  • 17. Pharmacologic control of heart rate in atrial fibrillation.
    Falk RH
    Cardiol Clin; 1996 Nov; 14(4):521-36. PubMed ID: 8950054
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Significance of neurotropic component in therapeutic effect of the anti-arrhythmia agents].
    Sheikh-Zade IuR; Cherednik IL; Galenko-Iaroshevskiĭ PA
    Biull Eksp Biol Med; 1999 Mar; 127(3):353-6. PubMed ID: 10225121
    [No Abstract]   [Full Text] [Related]  

  • 19. [Drug therapy of atrial fibrillation].
    Fazekas T; Csanádi Z; Varró A
    Orv Hetil; 2003 Jun; 144(24):1199-206. PubMed ID: 12866149
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Sotalol vs metoprolol for ventricular rate control in patients with chronic atrial fibrillation who have undergone digitalization: a single-blinded crossover study.
    Kochiadakis GE; Kanoupakis EM; Kalebubas MD; Igoumenidis NE; Vardakis KE; Mavrakis HE; Vardas PE
    Europace; 2001 Jan; 3(1):73-9. PubMed ID: 11271956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.